Actively Recruiting
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
Led by University of California, San Diego · Updated on 2026-02-10
2436
Participants Needed
2
Research Sites
198 weeks
Total Duration
On this page
Sponsors
U
University of California, San Diego
Lead Sponsor
U
University of Nigeria Nsukka
Collaborating Sponsor
AI-Summary
What this Trial Is About
While there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cancer screening and treatment (CCST) among WLHIV remains low. This study aims to leverage the available infrastructure for HIV care and treatment programs in Nigeria to integrate cervical cancer screening and treatment and conduct a cluster randomized, hybrid type III trial design to assess the comparative effectiveness of a Core set of implementation strategies versus a Core+ (enhanced) set of implementation strategies to implement cervical cancer screening, onsite treatment, referral and referral completion, treatment, and retention in care among WLHIV. The overarching goal is to improve the health and life expectancy of WLHIV with co-occurring cervical cancer.
CONDITIONS
Official Title
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women living with HIV
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
UC San Diego
La Jolla, California, United States, 92093
Actively Recruiting
2
University of Nigeria, Nsukka
Enugu, Enugu State, Nigeria
Actively Recruiting
Research Team
G
Gregory Aarons, PhD
CONTACT
E
Echezona Ezeanolue, MD, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here